Replimune Group Inc. laid off 224 Massachusetts employees last week. These cuts followed the FDA's second rejection of its lead cancer dr-g, RP1. The layoffs occurred across two facilities in Woburn and Framingham. The first wave eliminated 63 positions, followed by 161 additional cuts. Company filings suggest more employee reductions may be finalized soon.
Woburn, Massachusetts
https://www.masslive.com/news/2026/04/200-mass-biotech-employees-were-laid-off-last-week-that-may-only-be-the-beginning.html